• News
  • SAN DIEGO
  • BioTech

Cadence and Perrigo settle patent dispute

San Diego-based Cadence Pharmaceuticals Inc. (Nasdaq: CADX) said Wednesday that it settled a patent dispute with Perrigo Co. (Nasdaq: PRGO) on its only marketed drug, the fever and pain treatment Ofirmev.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!